The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
MicroRNA-based therapeutics in central nervous system injuries
Abstract
Central nervous system (CNS) injuries, such as stroke, traumatic brain injury (TBI) and spinal cord injury (SCI), are important causes of death and long-term disability worldwide. MicroRNA (miRNA), small non-coding RNA molecules that negatively regulate gene expression, can serve as diagnostic biomarkers and are emerging as novel therapeutic targets for CNS injuries. MiRNA-based therapeutics include miRNA mimics and inhibitors (antagomiRs) to respectively decrease and increase the expression of target genes. In this review, we summarize current miRNA-based therapeutic applications in stroke, TBI and SCI. Administration methods, time windows and dosage for effective delivery of miRNA-based drugs into CNS are discussed. The underlying mechanisms of miRNA-based therapeutics are reviewed including oxidative stress, inflammation, apoptosis, blood–brain barrier protection, angiogenesis and neurogenesis. Pharmacological agents that protect against CNS injuries by targeting specific miRNAs are presented along with the challenges and therapeutic potential of miRNA-based therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Diverse strategies in other CNS disease therapies utilize microRNA inhibitors,188 mimics,189 siRNAs,190 and ASOs191 to modulate treatment efficacy.”
From MiR-128-3p – a gray eminence of the human central nervous system (2024) · cites this paper as [189]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741 · cited 3×
“AntimiRs now refer to the modified ASOs having the full or partial complementary reverse sequence of a mature miRNA.(45,95)”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Neuronal replacement from endogenous precursors in the adult brain after stroke
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., & Lindvall, O. (2002) · Nature Medicine · doi:10.1038/nm747 · Cited by 2,799
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
MicroRNAs in cancer: biomarkers, functions and therapy
Hayes, J., Peruzzi, P. P., & Lawler, S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.005 · Cited by 2,049
MicroRNAs 103 and 107 regulate insulin sensitivity
Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M. (2011) · Nature · doi:10.1038/nature10112 · Cited by 1,000
Shi, Y., Zhang, L., Pu, H., Mao, L., Hu, X., Jiang, X., Xu, N., Stetler, R. A., Zhang, F., Liu, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms10523 · Cited by 431
Jovičić, A., Roshan, R., Moisoi, N., Pradervand, S., Moser, R., Pillai, B., & Luthi-Carter, R. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.0600-12.2013 · Cited by 251
Research works printed but not linked: 308
- 10.1038/35002607 · DOI
- 10.1038/ncb0309-228 · DOI
- 10.1080/07853890701771823 · DOI
- 10.1038/nrc1840 · DOI · Paper page
- 10.1038/sj.onc.1210425 · DOI
- 10.1007/s00441-007-0530-3 · DOI
- 10.1002/jcp.21639 · DOI
- 10.1038/nm0106-36 · DOI
- 10.4161/cbt.10.12.13437 · DOI
- 10.1016/S1470-2045(12)70372-8 · DOI
- 10.1073/pnas.0804549105 · DOI · Paper page
- 10.3892/ijo.2012.1647 · DOI
- 10.12688/f1000research.2-136.v1 · DOI
- 10.1038/nrg1990 · DOI · Paper page
- Filip A. [MiRNA – new mechanisms of gene expression control]. Postepy Biochem 2007; 53: 413–419.
- 10.1161/STROKEAHA.107.500736 · DOI
- 10.1038/jcbfm.2009.186 · DOI
- 10.1373/clinchem.2009.131797 · DOI
- 10.1089/neu.2011.2146 · DOI · Paper page
- 10.1371/journal.pone.0099283 · DOI
- 10.1016/j.jocn.2016.12.009 · DOI
- 10.1038/srep28148 · DOI
- 10.1089/neu.2016.4857 · DOI
- 10.1371/journal.pone.0112019 · DOI
- 10.1089/neu.2017.5111 · DOI
- 10.1002/jnr.21945 · DOI · Paper page
- 10.1001/jamapediatrics.2017.3884 · DOI
- 10.1080/02699052.2016.1213420 · DOI
- 10.1016/j.expneurol.2009.06.015 · DOI · Paper page
- 10.7150/ijbs.9058 · DOI
- 10.1038/sc.2014.86 · DOI
- 10.1038/s41598-017-01299-x · DOI
- 10.1016/j.tibtech.2014.09.002 · DOI
- 10.1186/gb-2010-11-8-r90 · DOI · Paper page
- 10.1002/wrna.1286 · DOI
- 10.1016/S0092-8674(04)00045-5 · DOI
- 10.1016/j.cell.2009.01.002 · DOI · Paper page
- 10.1242/jcs.03429 · DOI
- 10.1073/pnas.0510928103 · DOI
- 10.1038/nature03315 · DOI · Paper page
- 10.4103/2229-3485.179431 · DOI · Paper page
- Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomed 2012; 7: 49–60.
- 10.1056/NEJMoa1209026 · DOI
- 10.1038/nrd3179 · DOI
- 10.1016/j.nbd.2009.12.021 · DOI
- 10.1016/j.nbd.2011.09.012 · DOI
- 10.1007/s11064-014-1310-6 · DOI
- Xu L, Ouyang Y, Xiong X, et al. Post-stroke treatment with miR-181 antagomir reduces injury and improves long-term behavioral recovery in mice after focal cerebral ischemia. Exp Neurol 2014; 264C: 1–7. · DOI
- 10.2174/1871527311312030011 · DOI
- 10.1002/jnr.23255 · DOI
- 10.1016/j.brainres.2014.09.055 · DOI
- 10.1016/j.brainres.2014.09.072 · DOI
- 10.1161/STROKEAHA.114.007041 · DOI
- 10.1161/STROKEAHA.114.007482 · DOI
- 10.1161/STROKEAHA.117.017284 · DOI
- 10.1111/cns.12142 · DOI
- 10.1177/0271678X15610786 · DOI
- 10.1038/srep06718 · DOI · Paper page
- 10.1089/neu.2012.2748 · DOI · Paper page
- 10.1038/nrneurol.2013.67 · DOI · Paper page
- 10.1038/jcbfm.2011.45 · DOI
- 10.1073/pnas.1019055108 · DOI · Paper page
- Wang Z, Lu Y, Han J. Peripheral blood microRNAs: a novel tool for diagnosing disease? Intractable Rare Dis Res 2012; 1: 98–102.
- 10.1093/jnen/62.2.127 · DOI
- 10.1016/j.it.2005.08.007 · DOI
- 10.1016/S1474-4422(11)70066-7 · DOI
- 10.1038/nm.2507 · DOI
- 10.1038/nm.2399 · DOI · Paper page
- 10.1186/1742-2094-10-115 · DOI
- 10.1189/jlb.1109766 · DOI · Paper page
- 10.1038/jcbfm.2015.45 · DOI · Paper page
- 10.1080/00313020701230831 · DOI
- 10.1196/annals.1448.050 · DOI
- 10.2174/15680266113139990106 · DOI
- 10.1159/000351767 · DOI
- 10.4238/2012.January.27.1 · DOI
- Zeng L, Liu J, Wang Y, et al. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci 2011; 3: 1265–1272.
- 10.1161/CIRCRESAHA.117.311572 · DOI
- 10.5853/jos.2017.00423 · DOI
- 10.1016/j.jstrokecerebrovasdis.2017.09.058 · DOI
- 10.1089/neu.2010.1481 · DOI
- 10.1038/srep32651 · DOI
- 10.1371/journal.pone.0007689 · DOI
- 10.1212/WNL.0000000000003354 · DOI
- 10.1161/CIRCRESAHA.108.183426 · DOI
- 10.1007/s11897-011-0068-2 · DOI
- 10.1016/j.jconrel.2013.09.015 · DOI · Paper page
- 10.1038/gt.2011.50 · DOI
- 10.1161/CIRCRESAHA.111.247916 · DOI · Paper page
- 10.1261/rna.789808 · DOI · Paper page
- 10.15252/emmm.201100899 · DOI · Paper page
- 10.1261/rna.5103703 · DOI
- 10.1021/jm049167j · DOI
- 10.1080/15476286.2015.1020270 · DOI
- 10.1097/FJC.0b013e3181f605b6 · DOI
- 10.1016/0165-022X(90)90084-P · DOI
- 10.1161/CIRCRESAHA.110.227496 · DOI
- 10.1016/S0022-3565(24)38831-7 · DOI
- 10.1073/pnas.97.10.5633 · DOI · Paper page
- 10.1093/nar/gkq1270 · DOI
- 10.1093/nar/gkl183 · DOI · Paper page
- 10.1089/oli.2010.0238 · DOI · Paper page
- 10.1038/nature03121 · DOI
- 10.1038/nature13905 · DOI
- 10.1038/jhg.2016.53 · DOI
- 10.1016/j.bbadis.2016.11.034 · DOI
- 10.1016/j.abb.2015.09.018 · DOI
- 10.1016/bs.ircmb.2017.04.002 · DOI · Paper page
- 10.1002/wrna.1409 · DOI
- 10.1016/j.cjca.2017.01.001 · DOI
- 10.1016/j.pneurobio.2017.08.002 · DOI
- 10.1016/j.neuint.2017.01.015 · DOI
- 10.1007/s00221-017-4989-1 · DOI
- 10.1007/s12410-016-9389-6 · DOI
- 10.1161/CIRCULATIONAHA.109.928424 · DOI
- 10.1111/jcmm.12547 · DOI
- 10.1161/JAHA.113.000078 · DOI
- 10.1038/nm1582 · DOI
- 10.1161/CIRCULATIONAHA.112.000882 · DOI
- 10.1161/CIRCULATIONAHA.111.030932 · DOI
- 10.1038/cddis.2011.130 · DOI
- 10.1016/j.yjmcc.2014.07.009 · DOI
- 10.1126/science.1178178 · DOI · Paper page
- 10.1158/0008-5472.CAN-11-1144 · DOI
- 10.1002/hep.27153 · DOI
- 10.1038/nature06783 · DOI · Paper page
- 10.1038/nature10486 · DOI · Paper page
- 10.1002/emmm.201302647 · DOI
- 10.3389/fgene.2012.00120 · DOI
- 10.1158/0008-5472.CAN-10-0655 · DOI
- 10.1038/nm.2284 · DOI
- 10.1158/1535-7163.MCT-11-0152 · DOI
- 10.1038/ncomms3427 · DOI
- 10.1038/mt.2014.79 · DOI
- 10.1016/j.cell.2009.04.021 · DOI · Paper page
- 10.1016/j.ccr.2012.12.020 · DOI
- 10.1158/2159-8290.CD-13-0159 · DOI
- 10.1073/pnas.0800121105 · DOI
- 10.1158/0008-5472.CAN-10-3568 · DOI · Paper page
- 10.1073/pnas.1201516109 · DOI
- 10.1038/onc.2015.492 · DOI
- 10.1038/nrd4140 · DOI
- 10.1530/ERC-16-0525 · DOI
- 10.1016/j.omtn.2017.06.005 · DOI
- Bhalala OG. The emerging impact of microRNAs in neurotrauma pathophysiology and therapy. In: Kobeissy FH (ed.) Brain neurotrauma: Molecular neuropsychological and rehabilitation aspects. Boca Raton FL: CRC Press/Taylor & Francis 2015 Chapter 26.
- 10.3389/fneur.2015.00050 · DOI · Paper page
- 10.1038/jcbfm.2010.101 · DOI
- 10.1073/pnas.1121288109 · DOI · Paper page
- 10.1038/jcbfm.2013.68 · DOI
- 10.1038/jcbfm.2015.156 · DOI · Paper page
- 10.1371/journal.pone.0058039 · DOI
- 10.1074/jbc.M112.449025 · DOI
- 10.1161/STROKEAHA.116.015204 · DOI
- 10.1161/STROKEAHA.111.000613 · DOI
- 10.1007/s00401-013-1142-5 · DOI
- 10.1016/j.biomaterials.2016.03.025 · DOI · Paper page
- 10.1016/j.omtn.2017.04.010 · DOI · Paper page
- 10.1155/2013/350419 · DOI
- 10.1111/cns.12589 · DOI
- 10.1161/STROKEAHA.111.000504 · DOI · Paper page
- 10.1016/j.nbd.2013.11.023 · DOI
- 10.1016/j.bbi.2015.04.014 · DOI
- 10.1016/j.jns.2015.05.036 · DOI
- 10.1038/srep13316 · DOI
- 10.1016/j.neuroscience.2015.07.064 · DOI
- 10.1371/journal.pone.0128432 · DOI
- 10.1002/jcb.24960 · DOI
- 10.1007/s12035-015-9605-4 · DOI
- 10.3390/ijms17091427 · DOI
- 10.1177/0271678X15610786 · DOI
- 10.2147/NDT.S121183 · DOI
- 10.3892/etm.2017.4874 · DOI
- 10.1016/j.neuint.2016.10.008 · DOI
- 10.1038/jcbfm.2008.157 · DOI
- 10.1074/jbc.M110.144576 · DOI
- 10.1038/jcbfm.2013.157 · DOI
- 10.1016/j.expneurol.2014.11.007 · DOI
- 10.1038/mt.2014.113 · DOI
- 10.1002/jnr.23637 · DOI
- 10.1007/s12031-013-0155-9 · DOI
- 10.1523/JNEUROSCI.1641-15.2015 · DOI
- 10.1186/s12974-016-0753-x · DOI · Paper page
- 10.12659/MSM.898980 · DOI
- Liu W, Chen X, Zhang Y. Effects of microRNA-21 and microRNA-24 inhibitors on neuronal apoptosis in ischemic stroke. Am J Transl Res 2016; 8: 3179–3187.
- 10.1016/j.abb.2016.05.002 · DOI
- 10.1111/febs.13697 · DOI
- 10.1007/s11064-016-1975-0 · DOI
- 10.1016/j.nbd.2016.02.011 · DOI
- 10.1159/000447838 · DOI
- 10.1007/s12035-016-9842-1 · DOI
- 10.1093/jnen/nlx052 · DOI
- 10.1002/jcb.26181 · DOI
- 10.1016/j.nbd.2017.04.018 · DOI
- 10.1096/fj.201500126 · DOI
- 10.1523/JNEUROSCI.1260-14.2014 · DOI
- 10.1016/j.bbrc.2016.12.001 · DOI
- 10.1016/j.brainres.2015.01.009 · DOI · Paper page
- Sun L, Liu A, Zhang J, et al. miR-23b improves cognitive impairments in traumatic brain injury by targeting ATG12-mediated neuronal autophagy. Behav Brain Res 2017; 34: 3–14.
- 10.1096/fj.201700673R · DOI · Paper page
- 10.1038/cdd.2015.132 · DOI
200 of 308 shown
Cited by
Sorted by citations
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
Filannino, F. M., Panaro, M. A., Benameur, T., Pizzolorusso, I., & Porro, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031629 · Cited by 60
MicroRNAs change the games in central nervous system pharmacology
Marangon, D., Raffaele, S., Fumagalli, M., & Lecca, D. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.019 · Cited by 22
MiR-128-3p – a gray eminence of the human central nervous system
Kiel, K., Król, S. K., Bronisz, A., & Godlewski, J. (2024) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2024.102141 · Cited by 15
Metadata
- Authors
- Sun, P., Liu, D. Z., Jickling, G. C., Sharp, F. R., & Yin, K.-J.
- Affiliations
- Department of Neurology, Pittsburgh Institute of Brain Disorders & Recovery, <!---->University of Pittsburgh School of Medicine<!---->, Pittsburgh, PA, USA
- Department of Neurology and the M.I.N.D. Institute, University of California at Davis, Sacramento, CA, USA
- Department of Neurology, University of Alberta, Edmonton, Alberta, Canada
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2018-04-30
- Volume
- 38
- Issue
- 7
- Pages
- 1125-1148
- ISSN
- 0271-678X
- 1559-7016
- Cited by
- 228
- References
- 11
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review